Skip to main content
Journal of Palliative Medicine logoLink to Journal of Palliative Medicine
. 2011 Jun;14(6):683–687. doi: 10.1089/jpm.2010.0331

Impact of Combined Hospice Care on Terminal Cancer Patients

Song-Seng Loke 1,, Kung-Ming Rau 2, Chih-Fang Huang 1
PMCID: PMC3107584  PMID: 21504306

Abstract

Background

Many patients with advanced cancer will develop physical and psychological symptoms related to their disease. These symptoms are infrequently treated by conventional care. Palliative care programs have been developed to fill this gap in care. However, there are limited beds in hospice units. To allow more terminal cancer patients to receive care from a hospice team, a combined hospice care system was recently developed in Taiwan. This study is a report of our experiences with this system.

Patients and Methods

From January to December 2009, terminal cancer patients who accepted consultation from a hospice team for combined hospice care were enrolled in the study. Demographic data, clinical symptoms, referring department, type of cancer, and outcome were analyzed.

Results

A total of 354 terminal cancer patients in acute wards were referred to a hospice consulting team. The mean patient age was 61 years, and the proportion of males was 63.28%. After combined hospice care, there was a significant improvement in the sign rate of do-not-resuscitate (DNR) orders from 41.53% to 71.47% (p < 0.0001), and awareness of disease prognosis from 46.05% to 57.69% (p = 0.0006). Combined hospice care also enabled 64.21% of terminal cancer patients who were not transferred to hospice ward to receive combined care by a hospice consulting team while in acute wards, thus increasing the hospice utilization of terminal cancer patients. The major symptoms presented by the patients were pain (58%), dyspnea (52%), constipation (45%), and fatigue (23%).

Conclusions

Through the hospice consulting system, hospice combined care has a positive effect on the utilization of hospice care, rate of DNR signing and quality of end-of-life care for terminal cancer patients.

Introduction

Cancer has been the leading cause of death worldwide for more than two decades.1 Although improvements in cancer diagnosis and treatment mean that patients with cancer will live longer today than in the past, many patients with cancer are in the terminal stage when they are diagnosed. Many patients with advanced cancer will develop physical and psychological symptoms related to their disease, treatments, or comorbidities.2,3 These symptoms, which can significantly impair the patient's quality of life and family dynamics, are infrequently treated in conventional care. Palliative care programs have been developed to fill this gap in care. In many cases, these patients will benefit from specialized palliative care because many hospital-based integrated palliative care programs for patients with terminal cancer have been shown to improve symptom management and quality of life for patients and their families.4

As stated by Earle et al.,5 cardiopulmonary resuscitation (CPR), lack of hospice services during the last year of life, and dying in a hospital were some indicators of poor-quality end-of-life care for terminal cancer patients. In Taiwan, there were only 20 dedicated hospice units with 294 available beds.6 Given the limited number of hospice beds and the limited time available to most patients, some patients may not be able to wait for hospice care. Furthermore, because of the cultural tradition in Taiwan, certain Taiwanese consider death a taboo subject and view hospice wards as places to wait for death. A hospice consulting system has recently been developed in Taiwan to benefit terminal cancer patients who are waiting for hospice care in acute wards or who are hesitant to be transferred to a hospice ward. This enables terminal cancer patients to receive combined care by a hospice consulting team while they are still in acute cancer wards. In addition to helping with pain and symptom management, other aims of care are improving the quality of end-of-life care for terminal cancer patients through this combined hospice care. This study describes the initial results of our experiences with this program.

Methods

Terminal cancer patients who were admitted to a tertiary medical center located in southern Taiwan, from January to December 2009, and who accepted consultation from a hospice consultation system for combined hospice care in acute care wards were enrolled in the study. Questionnaire answers regarding demographics, symptoms and psychosocial needs, with a modified Chinese questionnaire similar to the Memorial Symptom Assessment Scale4 were evaluated and recorded. Ethical approval was obtained from the Institutional Review Board of Kaohsiung Chang Gung Memorial Hospital.

When terminal cancer patients in acute care wards are referred by the primary cancer physician, the members of the hospice consultation team evaluate the patient's general condition, provide suggestions for symptom control, psychosocial and family support, and identify and communicate goals of care. This process includes a meeting between the hospice team, primary cancer physician, and patient and family members. The hospice consultation team also helps the patient with dispositional planning, which includes evaluating possibilities such as transfer to a hospice ward for hospice care, discharge with hospice home care or other facility care, or combined care with a primary cancer physician in an acute ward. The hospice consultation team consists of palliative care physicians who are in charge of the hospice ward, hospice-qualified nurses, social workers, and a chaplain. Statistical analyses were performed using statistical software SAS (SAS 9.2 for Windows, SAS Institute, Cary, NC). The proportion of differences were analyzed using χ2 goodness-of-fit analysis. A p value of <0.05 was considered statistically significant.

Results

From January to December 2009, 354 terminal cancer patients were referred to the hospice consulting team in acute care cancer wards. The mean patient age was 61 years, and the proportion of males was 63.28%. Approximately half of the terminal cancer patients (48.31%) were referred by the hematology and oncology department, followed by the gastroenterology department (15.82%), and the chest department (9.89%) (Table 1). The most common type of cancer was hepatoma (17.23%), followed by lung cancer (15.25%) and colorectal cancer (13.28%) (Table 2). After combined hospice care, improvement was observed in the do-not-resuscitate (DNR) sign rate from 41.53% to 71.47% (p < 0.0001), awareness of disease prognosis from 46.05% to 57.69% (p = 0.0006), and awareness of disease status or diagnosis from 71.75% to 76.63% (p = 0.549). After consultation, 64.21% of the patients remained in the acute care cancer ward and received combined hospice care by his/her physician and the hospice consultation team. Only 20.12% of the patients were transferred to the hospice ward for palliative care only, and 15.67% were discharged (2.96% went home with hospice home care, 2.12% went home without hospice home care, and 10.59% went elsewhere). The average length of stay in the acute cancer ward with combined care by a hospice care team was 16.45 days. Of those patients receiving combined hospice care, 26.04% died in the acute care ward, 21.30% were discharged in predying status to die at home according to their wishes, and 16.87% were discharged for follow-up at their primary cancer physician outpatient clinic. The major symptoms presented to the hospice consultation team were pain (58%), dyspnea (52%), constipation (45%), and fatigue (23%) (Table 3). The psychosocial problems identified by the hospice consultation team are shown in Table 4. The most common problem was emotional disturbance.

Table 1.

Characteristics of Patients in Combined Hospice Care

  Number (n = 354) %
Age (years) 61  
Gender (M/F) 224/130 63.28/36.72
Mean days from consultation to termination of combined care 16.45  
Referring service:
 Hematology and Oncology 171 48.31
 Gastroenterology and Hepatology 56 15.82
 Pulmonology 35 9.89
 Proctology 33 9.32
 General surgery 12 3.39
 Urology 11 3.11
 Gynecology 10 2.82
 Neurosurgery 7 1.98
 General internal medicine 6 1.69
 Neurology 3 0.85
 Others 10 2.82

Table 2.

Primary Cancer

Cancer type Number (n = 354) %
Hepatoma 61 17.23
Lung, bronchus 54 15.25
Colorectal 47 13.28
Tongue, oropharynx 24 6.78
Breast 20 5.65
Renal, bladder 20 5.65
Stomach 18 5.08
Cervical, ovary 16 4.52
Pancreas 15 4.24
Esophagus 14 3.95
Biliary 13 3.67
Brain 7 1.98
Lymphoma 7 1.98
Nasopharynx 5 1.41
Others 33 9.32

Table 3.

Most Common Physical Symptoms

Symptom %
Pain 58
Dyspnea 52
Constipation 45
Fatigue 23
Confusion 6
Poor appetite 17
Oral ulcer 1
Flatulence 9
Ascites 6
Edema 8
Jaundice 3
Anorexia 14
Delirium 11
Insomnia 2
Predying status 4
Dysphagia 4
Itching 2
Fever 2

Table 4.

Most Common Psychosocial Symptoms

Symptom %
Emotional disturbance 53.29
Disease awareness and accommodation disturbance 34.29
Family support and accommodation problem 18.77
Lack of financial support 3.75
Unfinished business 3.25

Discussion

The overall rate of hospice utilization during the last year of life among terminal cancer patients in Taiwan is approximately 10%–17%.7,8 This is much lower than statistics from other countries. The prevalence of hospice utilization has been reported as 65% in the United States,9 19% (inpatient hospice) to 68% (hospice home care) in the United Kingdom,10 65%–68% in Australia,11,12 and 67% in Hong Kong.13 In order to increase the utilization rate of hospice care in Taiwan, a new hospice consulting system with combined hospice care for cancer patients was recently propagated. This study showed that with combined hospice care, more than half of the patients who remained in acute wards could be served by the hospice consulting team and only approximately one quarter were transferred to the hospice ward for total hospice care. This indicates that combined hospice care will give more patients with cancer the opportunity to receive care from a hospice team while remaining under the treatment of their primary cancer physician. Combined hospice care is additionally beneficial because the philosophy of hospice care does not appear to be widely accepted by cancer patients, family members, and even health care professionals, especially in Taiwan.

A DNR order is an end-of-life issue that is discussed with terminal cancer patients and their families. This study showed that the quality of end-of-life care was improved after combined hospice care, including a lower cardiopulmonary resuscitation rate, because there was a significant increase in the DNR sign rate for terminal cancer patients after receiving consultation from the hospice consulting system with combined hospice care. However, some terminal cancer patients did not sign a DNR because of late referral, predying status during consultation, or a hesitance to accept the hospice care philosophy. Lin et al.14 showed that terminal cancer patients who did not receive resuscitation cost significantly less than those who received resuscitation. Therefore, the hospice consulting team may have saved our facility unnecessary expenditure. Unfortunately, the design of our study did not allow us to quantitate these savings.

Many studies have shown that hospice and palliative care are cost-effective programs that reduce hospital admissions and improve the quality of life of terminally ill patients.1520 The adequate utilization of hospice services requires timely referral of terminally ill patients to hospice programs.21,22 Hospice care remains underutilized and patients are often referred to hospice very late in the course of their disease.2126 This may be because some terminal cancer patients want to continue cancer treatment options until they are too weak to tolerate them or because some patients think that hospice wards are places to go to die. In addition to combined hospice care, the hospice consulting team also offers psychosocial and emotional support, because the majority of terminal cancer patients, their family members, and the other caregivers will experience tremendous stress and psychosocial issues. For these reasons, the length of stay is expected to be shorter for patients receiving combined hospice care than for patients in the acute wards without hospice care. In this study, the average length of combined hospice care in acute cancer wards after consultation was 16.5 days, whereas a study by Ciemins et al.27 showed that there was a reduction in average length of stay following a palliative care consultation from 24 days to 13 days. The average length of stay of terminal cancer patients varied according to cancer type, disease trajectory, and treatment options.28 A short length of stay does not necessarily mean poor quality of care because patients may prefer to remain at home as long as possible. In fact, many patients express a wish to be at home during the last day of life.29 As noted by Cobbs30 and Grand et al.,31 home-based end-of-life care and dying at home is a gold standard of quality care. Our study also showed that with the support of the combined hospice team offered by consulting system, 21.3% of the patients preferred to be discharged in predying status to die at home, and 2.96% were discharged and continued care by a hospice home team.

There is some indication that the primary cancer physicians in acute care wards do not adequately educate their patients about their illnesses. In an earlier study by Low et al.32 only 69.7% of patients knew their diagnosis at the time of referral. In this study, only 71.75% knew their diagnosis at the time of referral. Doctors may be reluctant to reveal information to patients because of the families' wishes or feeling that they are inadequately trained to discuss such issues.33 After consultation and combined hospice care, there were no significant changes the patient's knowledge of their diagnosis or awareness of their disease status (p = 0.549). This may be because most families prefer not to inform the patients of their diagnosis.

Many studies have reported the incidence of cancer-related symptoms in patients referred to palliative care.3441 According to two analyses of patients with terminal cancer in varied palliative care settings, fatigue was the most frequently reported symptom, and pain, depression, and anxiety were the most distressing symptoms.2,42 In this study, the most frequently reported symptoms were pain (58%), dyspnea (52%), constipation (45%), and fatigue (23%). The incidence of presented symptoms could be related to the cancer type and site of metastasis. For example, a patient with lung cancer might have dyspnea as a main symptom, whereas a patient with bone metastasis might mainly complain of pain. In this study, lung cancer was the second most common cancer and bone metastasis was the most common site of metastasis (data not shown). A limitation of this study is that the modified Chinese questionnaire similar to the Memorial Symptom Assessment Scale that we used for initial evaluation was not used for all symptom follow-up assessment; therefore, several important variables, especially change of symptom frequency and severity, were not assessed after the patients received palliative consultation and combined care. This limitation, and because more than half of the terminal cancer patients in the study were in a confused, or predying state or had died during the combined hospice care, made follow-up assessment of symptoms difficult.

Another limitation of this study design is that it did not allow us to document whether there is a reduction in the average length of stay in the acute ward without combined hospice care, because all of the terminal cancer patients in our study received combined hospice care in the acute care ward. In the future, a large prospective study is needed to compare these interventions and their impact on length of stay and potential cost saving between terminal cancer patients who received consultation with combined hospice care and those without combined hospice care.

Braiteh et al.43 reported that palliative care consultation services in a comprehensive cancer center have a positive effect on patient care. We similarly report that palliative care consultation services with combined hospice care have improved the quality of end-of-life care for terminal cancer patients. Our findings should assist clinicians and administrators in the process of establishing palliative care consultation services with combined hospice care, especially for other developing countries that lack adequate hospice resource, or do not have inpatient hospice ward, so that more terminal cancer patients can get help from hospice care.

Acknowledgments

This study was supported by grant from Kaohsiung Chang Gung Memorial Hospital CMRP 880021.

Author Disclosure Statement

No competing financial interests exist.

References

  • 1.Kao YH. Chen CN. Chiang JK. Chen SS. Huang WW. Predicting factors in the last week of survival in elderly patients with terminal cancer: A prospective study in Southern Taiwan. J Formos Med Assoc. 2009;3:231–239. doi: 10.1016/S0929-6646(09)60057-7. [DOI] [PubMed] [Google Scholar]
  • 2.Bruera E. Neumann C. Brenneis C. Quan H. Frequency of symptom distress and poor prognostic indicators in palliative cancer patients admitted to a tertiary palliative care unit, hospices, and acute care hospitals. J Palliat Care. 2000;16:16–21. [PubMed] [Google Scholar]
  • 3.Kirkova J. Davis MP. Walsh D. Tiernan E. Leary NO. LeGrand SB. Lagman RL. Russell KM. Cancer symptom assessment instruments: A systemic review. J Clin Oncol. 2006;24:1459–1473. doi: 10.1200/JCO.2005.02.8332. [erratum in: J Clin Oncol 2006;24:2973]. [DOI] [PubMed] [Google Scholar]
  • 4.Portenoy RK. Thaler HT. Kornblith AB. Lepore JM. Friedlander-Klar H. Kiyasu E. Sobel K. Coyle N. Kemeny N. Norton L. The Memorial Symptom Assessment Scale: An instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer. 1994;30A:1326–1336. doi: 10.1016/0959-8049(94)90182-1. [DOI] [PubMed] [Google Scholar]
  • 5.Earle CC. Park ER. Lai B. Weeks JC. Ayanian JZ. Block S. Identifying potential indicators of quality of end-of-life cancer care from administrative data. J Clin Oncol. 2003;21:1133–1138. doi: 10.1200/JCO.2003.03.059. [DOI] [PubMed] [Google Scholar]
  • 6.Chang PM. Kiu YY. Chao TC. Lin HL. Chen MB. Chen PM. Chiou TJ. A new hospice consulting system for terminal cancer patients in transferring to post-acute care options in Taiwan. Eur J Cancer. 2010;19:262–272. doi: 10.1111/j.1365-2354.2008.00983.x. [DOI] [PubMed] [Google Scholar]
  • 7.Tang ST. Chen ML. Huang EW. Koong SL. Lin GL. Hsiao SC. Hospice utilization in Taiwan by cancer patients who died between 2000 and 2004. J Pain Symptom Manage. 2007;33:446–453. doi: 10.1016/j.jpainsymman.2006.09.027. [DOI] [PubMed] [Google Scholar]
  • 8.Tang ST. Huang EW. Liu TW. Wang HM. Chen JS. A population-based study on the determinants of hospice utilization in the last year of life for Taiwanese cancer decedents, 2001–2006. Psychooncology. 2010;19:1213–1220. doi: 10.1002/pon.1690. [Epub ahead of print]. [DOI] [PubMed] [Google Scholar]
  • 9.Connor SR. Elwert F. Spence C. Christakis NA. Geographic variation in hospice use in the United States in 2002. J Pain Symptom Manage. 2007;34:277–285. doi: 10.1016/j.jpainsymman.2007.03.007. [DOI] [PubMed] [Google Scholar]
  • 10.The National Council for Palliative Care. National survey of patient activity data for specialist palliative care services: MDS Full Report for the year 2005–2006. www.ncpc.org.uk/download/mds/MDS_Full_Report_2006.pdf. [Jun 4;2009 ]. www.ncpc.org.uk/download/mds/MDS_Full_Report_2006.pdf
  • 11.Rosenwax LK. McNamara BA. Who receives specialist palliative care in Western Australia—And who misses out. Palliat Med. 2006;20:439–445. doi: 10.1191/0269216306pm1146oa. [DOI] [PubMed] [Google Scholar]
  • 12.Currow DC. Burns CM. Abernethy AP. Place of death for people with noncancer and cancer illness in South Australia: A population-based survey. J Palliat Care. 2008;24:144–150. [PubMed] [Google Scholar]
  • 13.Tse D. Chan KS. Lam WM. Lau KS. Lam PT. The impact of palliative care on cancer deaths in Hong Kong: A retrospective study of 494 cancer deaths. Palliat Med. 2007;21:425–433. doi: 10.1177/0269216307079825. [DOI] [PubMed] [Google Scholar]
  • 14.Lin WY. Chiu TY. Hsu HS. Davidson LE. Lin T. Cheng KC. Chiu CF. Li CI. Chiu YW. Lin CC. Liu CS. Medical expenditure and family satisfaction between hospice and general care in terminal cancer patients in Taiwan. J Formos Med Assoc. 2009;10:794–802. doi: 10.1016/S0929-6646(09)60407-1. [DOI] [PubMed] [Google Scholar]
  • 15.Dawson NJ. Need satisfaction in terminal care settings. Soc Sci Med. 1991;32:83–87. doi: 10.1016/0277-9536(91)90131-u. [DOI] [PubMed] [Google Scholar]
  • 16.Brooks CH. Smyth-Staruch K. Hospice home care cost savings to third-party insurers. Med Care. 1984;22:691–703. doi: 10.1097/00005650-198408000-00002. [DOI] [PubMed] [Google Scholar]
  • 17.Mor V. Kidder D. Cost savings in hospice: Final results of the National Hospice Study. Health Serv Res. 1985;20:407–422. [PMC free article] [PubMed] [Google Scholar]
  • 18.Kidder D. The effects of hospice coverage on Medicare expenditures. Health Serv Res. 1992;27:195–217. [PMC free article] [PubMed] [Google Scholar]
  • 19.Robinson BE. Pham H. Cost effectiveness of hospice care. Clin Geriatr Med. 1996;12:417–428. [PubMed] [Google Scholar]
  • 20.Emanuel EJ. Ash A. Yu W. Levinsky NG. Saynina O. McClellan M. Moskowitz M. Managed care, hospice use, site of death, and medical expenditures in the last year of life. Arch Intern Med. 2002;162:1722–1728. doi: 10.1001/archinte.162.15.1722. [DOI] [PubMed] [Google Scholar]
  • 21.Christakis N. Escarce J. Survival of Medicare patients after enrollment in Hospice programs. N Eng J Med. 1996;335:172–178. doi: 10.1056/NEJM199607183350306. [DOI] [PubMed] [Google Scholar]
  • 22.Johnson CB. Hospice: What gets in the way of appropriate and timely access. Holist Nurs Prat. 1998;13:8–21. doi: 10.1097/00004650-199810000-00004. [DOI] [PubMed] [Google Scholar]
  • 23.Costantini M. Toscani F. Galluci M. Brunelli C. Miccinesi G. Tamburini M. Paci E. Di Giulio P. Peruselli C. Higginson I. Addington-Hall J. Terminal cancer patients and timing of referral to palliative care: A multicenter prospective cohort study. J Pain Symptom Manage. 1999;18:243–252. doi: 10.1016/s0885-3924(99)00084-6. [DOI] [PubMed] [Google Scholar]
  • 24.Virnig BA. McBean M. Kind S. Dholakia R. Hospice use before death: Variability across cancer diagnoses. Med Care. 2002;40:73–78. doi: 10.1097/00005650-200201000-00010. [DOI] [PubMed] [Google Scholar]
  • 25.Lamont EB. Christakis NA. Physician factor in the timing of cancer patient referral to hospice palliative care. Cancer. 2002;94:2733–2737. doi: 10.1002/cncr.10530. [DOI] [PubMed] [Google Scholar]
  • 26.McCarthy EP. Burns RB. Ngo-Metzger Q. Davis RB. Phillips RS. Barriers to hospice care among older patients dying with lung and colorectal cancer. J Clin Oncol. 2003;21:728–735. doi: 10.1200/JCO.2003.06.142. [DOI] [PubMed] [Google Scholar]
  • 27.Ciemins EL. Blum L. Nunley M. Newman JM. The ecomonic and clinical impact of an inpatient palliative care consultation service: A multifaceted approach. J Palliat Med. 2007;10:1347–1355. doi: 10.1089/jpm.2007.0065. [DOI] [PubMed] [Google Scholar]
  • 28.Quill TE. Is length of stay on hospice a critical quality of care indicator? J Palliat Med. 2007;10:290–292. doi: 10.1089/jpm.2006.9984. [DOI] [PubMed] [Google Scholar]
  • 29.Townsend J. Frank AO. Fermont D. Dyer S. Karran O. Walgrove A. Piper M. Terminal cancer care and patients' preferences for place of death: Prospective study. BMJ. 1990;301:415–417. doi: 10.1136/bmj.301.6749.415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Grande GE. Addingon-Hall JM. Todd CJ. Place of death and access to home care services: Are certain patient groups at a disadvantage? Soc Sci Med. 1998;47:565–579. doi: 10.1016/s0277-9536(98)00115-4. [DOI] [PubMed] [Google Scholar]
  • 31.Cobbs EL. Improving quality in end-of-life care: dying at home. J Am Geriatr Soc. 2001;49:831–832. doi: 10.1046/j.1532-5415.2001.49164.x. [DOI] [PubMed] [Google Scholar]
  • 32.Low JA. Pang WS. Lee A. Shaw RJ. A descriptive study of the demography, symptomology, management and outcome of the first 300 patients admitted to an independent hospice in Singapore. Ann Acad Med Singapore. 1998;27:824–829. [PubMed] [Google Scholar]
  • 33.Bulkin W. Lukashok H. Px for dying: The case for hospice. N Engl J Med. 1988;318:376–378. doi: 10.1056/NEJM198802113180609. [DOI] [PubMed] [Google Scholar]
  • 34.Cheung WY. Le LW. Zimmermann C. Symptom clusters in patients with advanced cancers. Support Care Cancer. 2009;17:1223–1230. doi: 10.1007/s00520-009-0577-7. [DOI] [PubMed] [Google Scholar]
  • 35.Teunissen SC. Wesker W. Kruitwagen C. de Haes HC. Voest EE. de Graeff A. Symptom prevalence in patients with incurable cancer: A systematic review. J Pain Symptom Manage. 2007;34:94–104. doi: 10.1016/j.jpainsymman.2006.10.015. [DOI] [PubMed] [Google Scholar]
  • 36.Kwon YC. Yun YH. Lee KH. Son KY. Park SM. Chang YJ. Wang XS. Mendoza TR. Cleeland CS. Symptoms in the lives of terminal cancer patients: which is the most important? Oncology. 2006;71:69–76. doi: 10.1159/000100450. [DOI] [PubMed] [Google Scholar]
  • 37.Maltoni M. Caraceni A. Brunelli C. Broeckaert B. Christakis N. Eychmueller S. Glare P. Nabal M. Viganò A. Larkin P. De Conno F. Hanks G. Kaasa: Prognostic factors in advanced cancer patients: Evidence-based clinical Recommendations—A study by the Steering Committee of the European Association for Palliative Care. J Clin Oncol. 2005;23:6240–6248. doi: 10.1200/JCO.2005.06.866. [DOI] [PubMed] [Google Scholar]
  • 38.Rees E. Hardy J. Ling J. Broadley K. A'Hern R. The use of the Edmonton Symptom Assessment Scale (ESAS) within a palliative care unit in the UK. Palliat Med. 1998;12:75–82. doi: 10.1191/026921698674135173. [DOI] [PubMed] [Google Scholar]
  • 39.Shorthose K. Andrew ND. Symptom prevalence in palliative care. Palliat Med. 2003;17:723–724. doi: 10.1177/026921630301700815. [DOI] [PubMed] [Google Scholar]
  • 40.Vainio A. Auvinen A. Prevalence of symptoms among patients with advanced cancer: An international collaborative study. Symptom Prevalence Group. J Pain Symptom Manage. 1996;12:3–10. doi: 10.1016/0885-3924(96)00042-5. [DOI] [PubMed] [Google Scholar]
  • 41.Maltoni M. Pirovano M. Scarpi E. Marinari M. Indelli M. Arnoldi E. Gallucci M. Frontini L. Piva L. Amadori D. Prediction of survival of patients terminally ill with cancer. Results of an Italian prospective multicentric study. Cancer. 1995;75:2613–2622. doi: 10.1002/1097-0142(19950515)75:10<2613::aid-cncr2820751032>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  • 42.Yennurajalingam S. Zhang T. Bruera E. The impact of the palliative care mobile team on symptom assessment and medication profiles in patient admitted to a comprehensive cancer center. Support Care Cancer. 2007;15:471–475. doi: 10.1007/s00520-006-0172-0. [DOI] [PubMed] [Google Scholar]
  • 43.Braiteh FS. EL Osta B. Palmer JL. Reddy SK. Bruera E. Characteristic findings, and outcomes of palliative care inpatient consultations at a comprehensive cancer center. J Palliat Med. 2007;10:948–955. doi: 10.1089/jpm.2006.0257. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Palliative Medicine are provided here courtesy of Mary Ann Liebert, Inc.

RESOURCES